Alexion Pharmaceuticals Inc. (ALXN) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Alexion Pharmaceuticals I...

    NASDAQ: ALXN · Real-Time Price · USD
    182.50
    0.00 (0.00%)
    At close: Apr 24, 2025, 3:47 PM

    Alexion Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q1 2021
    Period Ending Mar 31, 2021
    Net Income
    		 681.8M
    Depreciation & Amortization
    		 315.7M
    Stock-Based Compensation
    		 300.1M
    Other Working Capital
    		 12.2B
    Other Non-Cash Items
    		 2.14B
    Deferred Income Tax
    		 -279.5M
    Change in Working Capital
    		 -63.9M
    Operating Cash Flow
    		 3.09B
    Capital Expenditures
    		 -242.9M
    Cash Acquisitions
    		 -1.16B
    Purchase of Investments
    		 -23.4M
    Sales Maturities Of Investments
    		 54.9M
    Other Investing Acitivies
    		 -91.8M
    Investing Cash Flow
    		 -1.47B
    Debt Repayment
    		 n/a
    Common Stock Repurchased
    		 -403.7M
    Dividend Paid
    		 n/a
    Other Financial Acitivies
    		 -492.4M
    Financial Cash Flow
    		 -492.4M
    Net Cash Flow
    		 1.15B
    Free Cash Flow
    		 2.85B

    Add to Watchlist